Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Materials (Basel) ; 15(13)2022 Jun 21.
Article in English | MEDLINE | ID: mdl-35806515

ABSTRACT

With the rapid development of flexible electronic devices, flexible lithium-ion batteries are widely considered due to their potential for high energy density and long life. Anode materials, as one of the key materials of lithium-ion batteries, need to have good flexibility, an excellent specific discharge capacity, and fast charge-discharge characteristics. Carbon fibers are feasible as candidate flexible anode materials. However, their low specific discharge capacity restricts their further application. Based on this, N-doped carbon nanofiber anodes with microporous, mesoporous, and macroporous structures are prepared in this paper. The hierarchical and heterogeneous porosity structure can increase the active sites of the anode material and facilitate the transport of ions, and N-doping can improve the conductivity. Moreover, the N-doped flexible carbon nanofiber with a porous structure can be directly used as the anode for lithium-ion batteries without adding an adhesive. It has a high first reversible capacity of 1108.9 mAh g-1, a stable cycle ability (954.3 mAh g-1 after 100 cycles), and excellent rate performance. This work provides a new strategy for the development of flexible anodes with high performance.

2.
J Diabetes Investig ; 13(3): 525-531, 2022 Mar.
Article in English | MEDLINE | ID: mdl-34608767

ABSTRACT

AIMS/INTRODUCTION: In this paper, we focused on exploring the diagnostic and predictive clinical utility of ankle-brachial index (ABI) in combination with feet electrochemical skin conductance (FESC) for peripheral artery disease (PAD) in Chinese patients with type 2 diabetes mellitus (T2DM). MATERIALS AND METHODS: Overall, 183 Chinese T2DM patients were enrolled in this study. The patients were classified into three groups: Group 1 comprised of uncomplicated type 2 diabetics (n = 36), Group 2 consisted of patients with diabetic peripheral neuropathy (n = 103) whereas Group 3 patients displayed peripheral artery disease (n = 44). All patients underwent Sudoscan test using a Sudoscan (Paris, France) and ABI assessment. RESULTS: Multivariate logistic regression models revealed that FESC was an independent risk factor of developing PAD in patients with type 2 diabetes. The AUC for diagnostic, positive predictive and negative predictive value of ABI in combination with FESC for PAD were 0.907, 0.733 and 0.920, respectively. The specificity and sensitivity of ABI in combination with FESC for PAD were 0.914 and 0.750, respectively. CONCLUSIONS: Ankle-brachial index in combination with FESC can accurately be used in early diagnosis of PAD.


Subject(s)
Ankle Brachial Index , Diabetes Mellitus, Type 2 , Diabetic Neuropathies , Galvanic Skin Response , Peripheral Arterial Disease , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/diagnosis , Diabetic Neuropathies/complications , Humans , Peripheral Arterial Disease/complications , Peripheral Arterial Disease/diagnosis , Risk Factors
3.
Materials (Basel) ; 14(13)2021 Jun 27.
Article in English | MEDLINE | ID: mdl-34199094

ABSTRACT

Herein, the effect of Ni-doping amount on microstructure, magnetic and mechanical properties of Fe-based metallic microwires was systematically investigated further to reveal the influence mechanism of Ni-doping on the microstructure and properties of metallic microwires. Experimental results indicate that the rotated-dipping Fe-based microwires structure is an amorphous and nanocrystalline biphasic structure; the wire surface is smooth, uniform and continuous, without obvious macro- and micro-defects that have favorable thermal stability; and moreover, the degree of wire structure order increases with an increase in Ni-doping amount. Meanwhile, FeSiBNi2 microwires possess the better softly magnetic properties than the other wires with different Ni-doping, and their main magnetic performance indexes of Ms, Mr, Hc and µm are 174.06 emu/g, 10.82 emu/g, 33.08 Oe and 0.43, respectively. Appropriate Ni-doping amount can effectively improve the tensile strength of Fe-based microwires, and the tensile strength of FeSiBNi3 microwires is the largest of all, reaching 2518 MPa. Weibull statistical analysis also indicates that the fracture reliability of FeSiBNi2 microwires is much better and its fracture threshold value σu is 1488 MPa. However, Fe-based microwires on macroscopic exhibit the brittle fracture feature, and the angle of sideview fracture θ decreases as Ni-doping amount increases, which also reveals the certain plasticity due to a certain amount of nanocrystalline in the microwires structure, also including a huge amount of shear bands in the sideview fracture and a few molten drops in the cross-section fracture. Therefore, Ni-doped Fe-based metallic microwires can be used as the functional integrated materials in practical engineering application as for their unique magnetic and mechanical performances.

4.
Article in English | MEDLINE | ID: mdl-30873118

ABSTRACT

Purpose: We investigated the effects of Traditional Chinese Medicine (TCM) on the occurrence and progression of albuminuria in patients with type 2 diabetes. Methods: In this randomized, double-blind, multicenter, controlled trial, we enrolled 600 type 2 diabetes without diabetic nephropathy (DN) or with early-stage DN. Patients were randomly assigned (1:1) to receive Liuwei Dihuang Pills (LWDH) (1.5 g daily) and Ginkgo biloba Tablets (24 mg daily) orally or matching placebos for 24 months. The primary endpoint was the change in urinary albumin/creatinine ratio (UACR) from baseline to 24 months. Results: There were 431 patients having UACR data at baseline and 24 months following-up in both groups. Changes of UACR from baseline to follow-up were not affected in both groups: -1.61(-10.24, 7.17) mg/g in the TCM group and -0.73(-7.47, 6.75) mg/g in the control group. For patients with UACR ≥30 mg/g at baseline, LWDH and Ginkgo biloba significantly reduced the UACR value at 24 months [46.21(34.96, 58.96) vs. 20.78(9.62, 38.85), P < 0.05]. Moreover, the change of UACR from baseline to follow-up in the TCM group was significant higher than that in the control group [-25.50(-42.30, -9.56] vs. -20.61(-36.79, 4.31), P < 0.05]. Conclusion: LWDH and Ginkgo biloba may attenuate deterioration of albuminuria in type 2 diabetes patients. These results suggest that TCM is a promising option of renoprotective agents for early stage of DN. Trial registration: The study was registered in the Chinese Clinical Trial Registry. (no. ChiCTR-TRC-07000037, chictr.org).

5.
Complement Ther Med ; 40: 120-125, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30219436

ABSTRACT

OBJECTIVE: To evaluate the impact to oxidative stress, atherosclerosis and macrovascular disease by two proprietary herbal medicines including Ginkgo Leaf Tablets and Liuwei Dihuang Pills in type 2 diabetes. METHODS: The recruited 140 type 2 diabetes were randomly divided into the treatment group and control group which were both received basic diabetic management including anti-hyperglycemia, anti-hypertension, life style adjustment and health education etc. Additionally, the treatment group was given both Ginkgo Leaf Tablets and Liuwei Dihuang Pills while the control group was given placebos of Ginkgo Leaf Tablets and Liuwei Dihuang Pills. The relative clinical indexes about macrovascular events occurrence, atherosclerosis degree(IMT levels), oxidative stress in vivo(plasma carboxymethyl lysine(CML) and 8-isoprostane(8-IsoP) levels), plasma glucose, plasma lipid, blood pressure, other drugs usage situations and so on of two groups before and after consecutive 36-month treatment were accurately collected and statistically analyzed. RESULTS: There were no significant differences of cardiovascular disease, cerebrovascular disease, IMT levels, plasma CML and 8-IsoP levels between the two groups before treatment. After 36-month treatment, the plasma CML and 8-IsoP levels of treatment group were both significantly lower than control group (CML: 312.4 ± 90.4 ng/ml versus 463.5 ± 97.2 ng/ml, P < 0.0001; 8-IsoP: 23.7 ± 9.5 pg/ml versus 62.6 ± 16.1 pg/ml, P < 0.0001) although this improvement was not shared with IMT and macrovascular events. CONCLUSION: Ginkgo Leaf Tablets and Liuwei Dihuang Pills are beneficial to oxidative stress which plays important role in diabetic atherosclerosis and macrovascular complications. The preventive and therapeutic values of herbal medicines will be proved in further diabetic complication researches.


Subject(s)
Diabetes Mellitus, Type 2/drug therapy , Drugs, Chinese Herbal/therapeutic use , Plant Extracts/therapeutic use , Aged , Biomarkers/blood , Blood Pressure/drug effects , Diabetes Mellitus, Type 2/blood , Dinoprost/analogs & derivatives , Dinoprost/blood , Drugs, Chinese Herbal/pharmacology , Female , Ginkgo biloba , Humans , Lysine/analogs & derivatives , Lysine/blood , Male , Middle Aged , Oxidative Stress/drug effects , Plant Extracts/pharmacology
6.
Ren Fail ; 39(1): 698-701, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28994624

ABSTRACT

AIM: To explore the possible correlations between plasma heparanase and albuminuria, glucose and lipid metabolism in the type 2 diabetic nephropathy patients at the early stage. METHODS: One hundred and forty patients with type 2 diabetic nephropathy at early stage were recruited into the study. Plasma heparanase and the characterized advanced glycation end products (AGEs), carboxymethyllysine (CML) were measured by enzyme-linked immunosorbent assay. RESULTS: Plasma heparanase was positively associated with fasting blood glucose (R = 0.24, p = .01) while heparanase was not significantly correlated with the urinary microalbumin to creatinine ratio (urinary mAlb/Cr) (R = 0.05, p = .58) and CML (R = 0.16, p = .26). On stepwise linear regression analysis, fasting blood glucose was the main independent determinants of plasma heparanase concentration. CONCLUSION: Plasma heparanase is not significantly associated with urinary mAlb/Cr while it is correlated positively with blood glucose levels in the early stage of diabetic nephropathy. Plasma heparnase might be regarded as a marker for vascular endothelial cells injury in diabetic patients.


Subject(s)
Albuminuria/blood , Diabetic Nephropathies/blood , Glucuronidase/blood , Aged , Blood Glucose , Diabetes Mellitus, Type 2/complications , Diabetic Nephropathies/etiology , Female , Humans , Male , Middle Aged
7.
Article in English | MEDLINE | ID: mdl-28077949

ABSTRACT

Objective. To observe the clinical prophylactic and therapeutic efficacy of Liuwei Dihuang Pills and Ginkgo Leaf Tablets for type 2 diabetic vascular complications. Methods. It was a randomized, double-blind and placebo-controlled clinical trial. 140 outpatients with type 2 diabetes were recruited and randomly divided into the treatment group and control group. The two groups were given basic therapy (management of blood sugar, blood pressure, etc.). Additionally, the treatment group was given Liuwei Dihuang Pills and Ginkgo Leaf Tablets, while the control group was given Liuwei Dihuang Pills and Ginkgo Leaf Tablets placebos. All subjects were followed up for consecutive 36 months and observed monthly. The clinical data as urinary microalbumin to urinary creatinine ratio (Umalb/cr), carotid intima-media thickness (IMT), diabetic nephropathy (DN) and diabetic retinopathy (DR) prevalence, cardiovascular and cerebrovascular events, blood glucose, and blood pressure were collected and analyzed statistically. Results. After 36-month treatment, the Umalb/cr level and DN and DR prevalence in treatment group were all significantly lower than control group (P < 0.05). However, the IMT level and the incidence of cardiovascular and cerebrovascular events were not significantly different between the two groups (P > 0.05). Conclusions. Liuwei Dihuang Pills and Ginkgo Leaf Tablets are beneficial to diabetic microvascular complications, while the efficacy to diabetic macrovascular complications needs more observations.

8.
J Med Food ; 15(5): 461-8, 2012 May.
Article in English | MEDLINE | ID: mdl-22439874

ABSTRACT

Diabetic nephropathy (DN) is an important diabetic complication, and podocyte apoptosis plays a critical role in the development of DN. In the present study, we examined the preventive effect of the total flavone glycosides of Flos Abelmoschus manihot (TFA) on urinary microalbumin and glomerular podocyte apoptosis in experimental DN rats. The preliminary oral administration of TFA (200 mg/kg/day) for 24 weeks significantly decreased the urinary microalbumin to creatinine ratio and 24-h urinary total protein in streptozotocin-induced DN rats. Terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling assay indicated glomerular cell apoptosis in DN rats was significantly improved by pretreatment with TFA. Furthermore, fluorescence-activated cell sorting and Hoechst 33342 staining suggested preincubation with hyperoside (50 and 200 µg/mL), the major active constituent of TFA, could significantly mitigate cultured podocyte apoptosis induced by the advanced glycation end-products (AGEs). Western blot analysis showed that increased caspase-3 and caspase-8 expressions induced by AGEs were also inhibited by pretreatment with hyperoside at both doses. Our results demonstrate that TFA pretreatment can decrease urinary albumin excretion in early-stage DN, which might be accomplished by preventing renal damage and podocyte apoptosis.


Subject(s)
Abelmoschus/chemistry , Apoptosis/drug effects , Diabetic Nephropathies/drug therapy , Flavones/therapeutic use , Phytotherapy , Podocytes/drug effects , Quercetin/analogs & derivatives , Albuminuria/drug therapy , Albuminuria/urine , Animals , Caspase Inhibitors , Creatinine/urine , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Experimental/urine , Diabetic Nephropathies/metabolism , Drugs, Chinese Herbal/pharmacology , Drugs, Chinese Herbal/therapeutic use , Flavones/pharmacology , Flowers , Glycation End Products, Advanced/metabolism , Glycosides/pharmacology , Glycosides/therapeutic use , Male , Mice , Quercetin/pharmacology , Quercetin/therapeutic use , Rats , Rats, Sprague-Dawley
9.
Diabetes Res Clin Pract ; 87(2): 157-60, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19945761

ABSTRACT

AIMS: The interaction of advanced glycation end products (AGEs) and the receptor for advanced glycation end products (RAGE) has played an important role in the pathogenesis of diabetic nephropathy. In the present study, we measured the relationship of plasma soluble isoform of RAGE (sRAGE) and urinary microalbumin excretion in the early stage of type 2 diabetic nephropathy. METHODS: 180 patients with early stage of type 2 diabetic nephropathy were recruited into the study. Plasma sRAGE and the characterized AGE carboxymethyllysine (CML) were measured by enzyme-linked immunosorbent assay. RESULTS: Plasma sRAGE positively correlated with the level of CML (R=0.22, P=0.03) while sRAGE was not significantly correlated with the urinary mAlb/Cr (R=0.15, P=NS). On stepwise linear regression analysis, AGE and GFR were the main independent determinants of plasma sRAGE concentration. CONCLUSION: Plasma sRAGE is not significantly associated with urinary microalbumin excretion in the early stage of diabetic nephropathy while it is correlated positively with circulating AGE and negatively with glomerular filtration rate (GFR).


Subject(s)
Albuminuria/epidemiology , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/urine , Diabetic Nephropathies/blood , Receptors, Immunologic/blood , Age of Onset , Aged , Blood Glucose/analysis , Blood Pressure , Body Mass Index , Diabetic Nephropathies/physiopathology , Diabetic Nephropathies/urine , Enzyme-Linked Immunosorbent Assay , Female , Glomerular Filtration Rate , Glycated Hemoglobin/metabolism , Humans , Lipids/blood , Lysine/analogs & derivatives , Lysine/blood , Male , Middle Aged , Patient Selection , Receptor for Advanced Glycation End Products
10.
Diabetes Res Clin Pract ; 87(3): e19-22, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20031245

ABSTRACT

Our studies suggest that plasma soluble advanced glycation end products (sRAGEs) has significantly negative association with high sensitivity C-reactive protein (hs-CRP) in 245 type 2 diabetes patients without diagnosed coronary artery disease (CAD). sRAGE maybe act as a novel biomarker for predicting the atherosclerosis in diabetes at the early stage.


Subject(s)
C-Reactive Protein/metabolism , Coronary Artery Disease/blood , Diabetes Mellitus, Type 2/blood , Glycation End Products, Advanced/blood , Aged , Coronary Artery Disease/complications , Diabetes Mellitus, Type 2/complications , Female , Humans , Male , Middle Aged , Regression Analysis
11.
J Agric Food Chem ; 57(9): 3808-17, 2009 May 13.
Article in English | MEDLINE | ID: mdl-19296579

ABSTRACT

Intramuscular fat content is important for many meat quality parameters. This work is aimed at identifying functional categories of genes associated with natural variation among individuals in intramuscular fat content to help the design of genetic schemes for high marbling potential. Taking advantage of the global nature of transcriptomic and proteomic technologies, 40 genes were identified as differently expressed between high fat and low fat pig Longissimus muscles at slaughter weight. They are involved in metabolic processes, cell communication, binding, and response to stimulus. Using real-time PCR in muscle biopsies taken earlier in the fattening period, the group with a high intramuscular fat content was also characterized by the down-expression of genes playing a negative role in adipogenesis, such as architectural transcription factor high-motility hook A1, mitogen activated protein-kinase14, and cyclin D1. These results suggest that interindividual variability in intramuscular fat content might arise essentially from differences in early adipogenesis.


Subject(s)
Adiposity , Gene Expression Profiling , Gene Expression Regulation , Muscle, Skeletal/chemistry , Proteomics , Swine , Adipogenesis , Animals , Female , Lipids/analysis , Meat/analysis , Muscle Proteins/analysis , Oligonucleotide Array Sequence Analysis , Reverse Transcriptase Polymerase Chain Reaction
12.
Neurosci Lett ; 440(2): 109-12, 2008 Aug 01.
Article in English | MEDLINE | ID: mdl-18562103

ABSTRACT

Utilizing the method of push-pull perfusion and radioimmunoassay (RIA), the secretory profile of gonadotropin-releasing hormone (GnRH) in the preoptic area (POA) and serum-luteinizing hormone (LH) levels were examined in conscious male rats after administration of [Nphe(1)]NC(1-13)NH(2), a competitive antagonists of the opioid receptor-like 1 receptor (ORL1 receptor) which is endogenous receptor for Orphanin FQ (OFQ). Glutamate release in the POA was also measured by high-performance liquid chromatography (HPLC) after perfusion of [Nphe(1)]NC(1-13)NH(2), i.e. NC13. The results showed that GnRH secretion from the POA and serum LH levels was increased significantly 40 min and 60 min, respectively after perfusion of 2 and 20 mmol/L NC13 in freely moving male rats (p<0.05). Pretreatment with a glutamate, N-methyl-D-aspartate (NMDA) receptor antagonist (MK-801, s.c., 0.2 mg/kg) abolished the increase of GnRH release in the POA induced by 2 mmol/L NC13. Additionally, 20 mmol/L NC13 significantly enhanced glutamate release in the POA at 40 min post-perfusion in a dose-dependent manner. These findings suggest that hypothalamic OFQ/ORL1 receptor system plays a role in the physiological inhibitory control of GnRH secretion in the POA of male rats, and provide evidence for involvement of an OFQ and glutamate pathway in the control of GnRH secretion.


Subject(s)
Glutamic Acid/physiology , Gonadotropin-Releasing Hormone/metabolism , Opioid Peptides/physiology , Preoptic Area/metabolism , Animals , Chromatography, High Pressure Liquid , Dizocilpine Maleate/administration & dosage , Dizocilpine Maleate/pharmacology , Dose-Response Relationship, Drug , Excitatory Amino Acid Antagonists/administration & dosage , Excitatory Amino Acid Antagonists/pharmacology , Glutamic Acid/analysis , Glutamic Acid/metabolism , Gonadotropin-Releasing Hormone/analysis , Luteinizing Hormone/blood , Luteinizing Hormone/metabolism , Male , Narcotic Antagonists , Opioid Peptides/administration & dosage , Opioid Peptides/pharmacology , Peptide Fragments/administration & dosage , Peptide Fragments/pharmacology , Preoptic Area/drug effects , Radioimmunoassay , Rats , Rats, Sprague-Dawley , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Receptors, Opioid/agonists , Vasodilator Agents/administration & dosage , Vasodilator Agents/pharmacology , Nociceptin Receptor , Nociceptin
SELECTION OF CITATIONS
SEARCH DETAIL
...